A Multi-centre, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of SB-649868 (10, 30 mg and 60 mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia

Name: A Multi-centre, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of SB-649868 (10, 30 mg and 60 mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Creator: Vivli
Published: 2018-10-27T11:55:53+08:00

DataCite Commons2025-01-06 更新2026-05-07 收录

失眠症药物临床试验

失眠评估

数据链接：

https://search.vivli.org/doiLanding/studies/00000460/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This study to evaluate the effects of SB-649868 (10, 30 mg and 60 mg) on sleep continuity, PSG sleep recordings, subjective sleep assessment, and daytime cognitive function in subjects with primary insomnia

提供机构：

Vivli

创建时间：

2018-10-27